Page 36 - International Space Station Benefits for Humanity, 3rd edition.

Kibo Exposed Facility will play a key role in establishing
a mass-data communication system between multiple
JAXA has focused the use of Kibo satellites or a satellite and a ground operation interface.
facilities for drug design, aging This innovation is also widely open for future longer-
distance optical fiber communication.
research, small satellite orbital In closing, the sustained use of the ISS and the
deployment, and space environment Japanese Kibo module, to their full extent through
exposure by academic, commercial 2024 and beyond, shows significant promise for
continued scientific, innovative and economic
and public entities worldwide. developments.

ROSCOSMOS State Corporation for
Space Activities
end-users with high-quality utilization services for Kibo State Space Corporation ROSCOSMOS (ROSCOSMOS)
facilities. As these partnerships deepen, operational is enabling the transition of the Russian Segment of the
know-how will be passed on and, thus, a new market ISS (ISS RS) to focus on the end user. Plans include
will be formed. creating an operating organization to provide ISS RS
utilization services to interested ministries, government
Commercially, the agency has partnered with
companies such as PeptiDream Inc. and Sony departments and private companies. A goal, by 2025,
Computer Science Laboratories (Sony CSL) to is to increase user-funded applied research that is
carried out to solve practical problems up to 45%
provide new pathways for research and technology
development. Furthermore, JAXA has invited Asian of the total research conducted in the ISS RS. It
is expected that expanding cooperation between
and Pacific nations to participate in the use of Japanese
facilities to promote diverse partnerships utilizing the ROSCOSMOS and an operating organization will
ISS. For example, a recent agreement with Singapore promote the formation of new organizations and
groups that will focus on attracting end-user funding
aims to use the Japanese Experiment Module (JEM)
Small Satellite Orbital Deployer (J-SSOD) to launch for targeted work on the ISS RS. All these actions
promote the operational expansion of the ISS RS
a Singaporean satellite. in a variety of research areas while maximizing the
JAXA’s focus is on promoting strategic partnerships to impact and economic effect, as well as obtaining
commercially establish the Research and Development significant results in scientific and applied research.
testbed aboard the Kibo module. One example is a new Currently, ROSCOSMOS is focusing its attention on
fee-based agreement with the Japanese drug discovery
company, PeptiDream Inc. The agreement increased the development of additive technologies in partnership
the number of protein samples from five to 30 over with private companies. ROSCOSMOS is currently
developing a new research infrastructure for unique
the lifetime of the agreement. JAXA also doubled the
launching frequency from twice to four times a year biomedical experiments on the ISS. In particular, as
a part of commercial cooperation, three-dimensional
to meet the requirements from PeptiDream and other
users. This accelerates the development of new drugs (3-D) bioprinting is being developed as an addition
while reducing overall research costs. Furthermore, the
company can expand Kibo utilization in its collaborative
research activities with other entities. Such benefits
strongly appeal to potential candidates of commercial Plans include creating an operating
users who have already participated in the Kibo
experimental programs since 2013, including organization to provide ISS RS
Chugai Pharmaceutical Co., Ltd and Taiho utilization services to interested
Pharmaceutical Co., Ltd.
The Space Exploration Innovation Hub program by ministries, government departments
JAXA created another successful partnership with and private companies.
Sony CSL. JAXA’s already-existing IVA-replaceable
Small Exposed Experiment Platform (i-SEEP) on the

22